MAPS technology may generate vaccines conferring strong immunity at reduced cost and risk
A new method of vaccine design, called the Multiple Antigen Presentation System (MAPS), may result in vaccines that bring together the benefits of whole-cell and acellular or defined subunit vaccination. The method, pioneered by researchers at Boston Children’s Hospital, permits rapid construction of new vaccines that activate mulitple arms of the immune system simultaneously against one or more pathogens, generating robust immune protection with a lower risk of adverse effects.
As reported by Fan Zhang, PhD, Ying-Jie Lu, PhD, and Richard Malley, MD, from Boston Children’s Division of Infectious Disease, in the Proceedings of the National Academy of Sciences on July 29, the method could speed development of new vaccines for a range of globally serious pathogens, or infectious agents.
Broadly speaking, the vaccines available today fall into two categories: whole-cell vaccines, which rely on weakened or killed bacteria or viruses; and acellular or subunit vaccines, which include a limited number of antigens—portions of a pathogen that trigger an immune response. Both approaches have advantages and disadvantages.
“Whole-cell vaccines elicit a broad range of immune responses, often just as an infection would, but can cause side effects and are hard to standardize,” said Malley. “Acellular vaccines can provide good early immunity with less risk of side effects, but the immune responses they induce wane with time.”
The MAPS method may allow vaccine developers to take a middle ground, where they can link multiple protein and polysaccharide (sugar) antigens from one or more pathogens together in a modular fashion, much as one would connect Lego blocks.
The resulting complex—which resembles a scaffold of polysaccharides studded with proteins—can stimulate both antibody and T-cell responses simultaneously much like whole-cell vaccines, resulting in stronger immunity to the source pathogen(s). However, because the composition of a MAPS vaccine is well defined and based on the use of isolated antigens (as one would find with an acellular vaccine) the risk of side effects should be greatly reduced.
For instance, mice injected with a MAPS vaccine combining proteins from tuberculosis (TB) and polysaccharides from Streptococcus pneumoniae (pneumococcus) mounted vigorous antibody and T-cell responses against TB, whereas those vaccinated with TB protein antigens alone mounted only an antibody response.
Similarly, 90 percent of mice given a MAPS-based vaccine containing multiple pneumococcal polysaccharide and protein antigens were protected from a lethal pneumococcus infection, mounting strong antibody and T-cell responses against the bacteria. By contrast, 30 percent of mice vaccinated with the same antigens in an unbound state survived the same challenge.
“The MAPS technology gives you the advantages of: whole-cell vaccines while being much more deliberate about which antigens you include; doing it in a quantitative and precise way; and including a number of antigens so as to try to replicate the effectiveness of whole-cell vaccination,” Malley explained. “The immunogenicity of these constructs is greater than the sum of their parts, somewhat because they are presented to the host as particles.”
The system relies on the interactions of two compounds, biotin and rhizavidin, rather than covalent binding as is used in most of the current conjugate vaccines. To build a MAPS vaccine, biotin is bound to the polysaccharide(s) of choice and rhizavidin to the protein(s). The biotin and rhizavidin then bind together through an affinity interaction analogous to Velcro. The construction process is highly efficient, significantly reducing the time and cost of vaccine development and production.
The Latest Bing News on:
Vaccine design
- Breakthrough vaccine strategy guides the immune system to generate HIV neutralizing antibodieson May 9, 2024 at 10:19 pm
A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing ...
- Antitumor Immunity Boosted by Chitin-Derived Vaccine Adjuvanton May 9, 2024 at 9:50 pm
C100 injections led to synergistic therapeutic effects with anti-PD1 immune checkpoint blockade (ICB) therapy in a preclinical model.
- GPS-like system shows promise as HIV vaccine strategy to elicit critical antibodieson May 9, 2024 at 6:38 am
A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing ...
- Pioneering Study Suggests Vaccines Could End Eczema’s Itch for Goodon May 8, 2024 at 9:01 am
New research from a multi-disciplinary team at Trinity College Dublin suggests a “tailored vaccine” might hold the key to treating bacteria-driven flares of eczema in children. The team has taken seve ...
- Tailored vaccine could one day treat eczema in childrenon May 8, 2024 at 9:00 am
New research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven flares of eczema in children. The work has been ...
- A tailored vaccine could one day treat eczema in childrenon May 7, 2024 at 5:00 pm
Pinpointing these signatures provides them with specific new targets, which is helpful from a theoretical vaccine design perspective. Working with 93 children between 0 and 16, the researchers ...
- Tailored vaccine may hold the key to treating eczema in childrenon May 7, 2024 at 5:00 pm
Pinpointing these signatures provides them with specific new targets, which is helpful from a theoretical vaccine design perspective. Working with 93 children between 0 and 16, the researchers ...
- This new vaccine could protect us from all coronaviruses — even those that don’t exist yeton May 7, 2024 at 11:31 am
A team of scientists from Cambridge University have developed a vaccine that works against the common elements of all coronaviruses. The vaccine, which has only been tested on mice so far, promises to ...
- New mRNA cancer vaccine helps immune system fight deadly brain tumorson May 7, 2024 at 8:23 am
Researchers from the University of Florida have developed a new mRNA cancer vaccine to retrain the body's immune system to attack and potentially treat glioblastoma, a deadly form of brain cancer.
- Research aims to develop vaccine against future COVID viruseson May 6, 2024 at 7:48 am
Scientists are busy working on a vaccine that might fight strains of the COVID virus SARS-CoV-2 that haven't even emerged yet.
The Latest Google Headlines on:
Vaccine design
[google_news title=”” keyword=”Vaccine design” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
MAPS-based vaccine
- GP reports of whooping cough cases mapped as five babies die and cases 90 times higheron May 12, 2024 at 3:58 am
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
- Whooping cough suspected outbreaks mapped as five babies die and cases 90 times higheron May 12, 2024 at 3:56 am
Tragically, five babies have died between January and March, the UK Health Security Agency (UKHSA) confirmed. There have been 1,319 lab-confirmed cases in March. That follows 556 cases in January and ...
- IHS National E3 Vaccine Strategy Launches Pilot Community Development Projecton May 11, 2024 at 7:24 pm
I announced the IHS National E3 Vaccine Strategy to ensure that we offer every patient at every encounter every recommended vaccine, when appropriate. Vaccination is our agency’s clinical and public ...
- Whooping cough map shows five UK areas where disease is spreading quickest - full liston May 10, 2024 at 10:11 am
The data, pinned onto an interactive map, reveals the locations of suspected outbreaks after the death of five babies.
- MIT Technology Reviewon May 9, 2024 at 4:59 pm
The draft map was based on brain tissue from just two donors ... (CNN) Long read: The covid vaccine, like all vaccines, can cause side effects. But many people who say they have been harmed by the ...
- MSU vaccine-tech spinoff hopes it can make lightning strike againon May 8, 2024 at 8:57 am
Parfet is managing director of Kalamazoo-based Apjohn Group LLC ... s technology involves what is termed a mutant-bacteriophage vaccine platform to make next-generation vaccines to target cancers ...
- AstraZeneca withdraws COVID-19 vaccine citing low demandon May 8, 2024 at 7:46 am
The U.K.-based pharmaceutical firm, known for its popular cancer drugs, entered the COVID-19 crisis with little experience developing vaccines. And the success of Vaxzevria was far from guaranteed.
- A tailored vaccine shows promise in treating childhood eczemaon May 8, 2024 at 1:06 am
Researchers say a new "tailored" vaccine shows promise in treating eczema flares caused by a certain bacteria in children ...
- New vaccine effective against coronaviruses that haven’t even emerged yeton May 6, 2024 at 3:39 am
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for ...
- Cholera is making a comeback — and the world doesn’t have enough vaccineson May 2, 2024 at 3:30 am
In an email to Vox, Sanofi said that the decision to exit the cholera vaccine market was not about profitability, but rather based on an understanding that ... and other stakeholders — had released a ...
The Latest Google Headlines on:
MAPS-based vaccine
[google_news title=”” keyword=”MAPS-based vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]